Cell fate conversion of differentiated somatic cells into glial cells
AssigneeCase Western Reserve University
InventorsPaul J. Tesar, Robert H. Miller, Fadi J. Najm
Life of this patent
Estimating the term…
Abstract
The present invention relates to the reprogramming of differentiated somatic cells, such as those differentiated cells that arise from embryonic mesoderm, into glial cells. Glial cells produced from this reprogramming are functionally equivalent to glial cells that arise from ectodermal origins.
Claims15
A method of promoting myelination in the central nervous system (CNS) of a subject in need thereof, the method comprising directly administering at a site within the CNS of the subject a therapeutically effective amount of an isolated population of reprogrammed glial cells, thereby enhancing myelination at the site of administration, wherein the isolated population of reprogrammed glial cells is generated by:
- providing somatic cells from the subject;
- culturing said somatic cells;
- infecting somatic cells with a retroviral vector to deliver reprogramming factors Sox 10, Olig2, and Nkx6.2;
- inducing expression of reprogramming factors Sox 10, Olig2, and Nkx6.2 in said cultured somatic cells under conditions to reprogram the somatic cells into a population of glial cells, wherein the glial cells express endogenous gene Olig2;
- and
- sorting said population of re-programmed glial cells from non-programmed cultured somatic cells to produce an enriched population of re-programmed glial cells.
Dependencies are inferred from the claim text.